Cancer Care Portal | Latest News, Research, and Support

From Medical Trials to CAR-T Cell Remedy: A Affected person’s Journey With Myeloma

How Caregivers Can Assist Liked Ones With Lung Most cancers Really feel in Management

Household Begins AYA Most cancers Basis After Lymphoma Prognosis

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Professional Discusses FDA Approval of Chemo-Free Possibility for EGFR-Mutated Lung Most cancers

The Cancer

Belief Instincts When Looking for the Proper Most cancers Care Staff

February 13, 2026

Genomic Testing Guides Therapy for Affected person With Lung Most cancers

February 13, 2026

Mother with Stage 4 Lung Most cancers Highlights Biomarker Testing

February 12, 2026

Delving Into Dwelling Donation, Advocacy and Life After Liver Transplant

February 12, 2026

Breast Most cancers Survivorship Myths Dispelled

February 12, 2026

Editor - May 4, 2026

NCI’s Message and High Priorities

NCI’s Message and High Priorities

May 4, 2026

What Are Embolism Warning Indicators for Sufferers With Most cancers?

February 13, 2026

Proton Remedy Improves Survival in Sufferers With Decrease Grade Glioma

February 13, 2026

Issues of the Coronary heart: Managing Cardiac Well being in Most cancers Survivorship

February 13, 2026

Belief Instincts When Looking for the Proper Most cancers Care Staff

February 13, 2026

Genomic Testing Guides Therapy for Affected person With Lung Most cancers

February 13, 2026

Don't Miss

NCI’s Message and High Priorities

What Are Embolism Warning Indicators for Sufferers With Most cancers?

Proton Remedy Improves Survival in Sufferers With Decrease Grade Glioma

Issues of the Coronary heart: Managing Cardiac Well being in Most cancers Survivorship

Belief Instincts When Looking for the Proper Most cancers Care Staff

News

FDA Clears Protocol Replace for Tasquinimod in Myelofibrosis Trial

Editor - February 11, 2026

Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...

News

How Most cancers Stole My Peace of Thoughts and Taught Me Resilience

Editor - February 11, 2026

Being robbed is simply part of life.Once I was in grammar college, little girls and boys would copy off my exams, stealing my solutions to...

News

FDA Clears PD-L1 Check to Information Keytruda Use in Ovarian Most cancers

Editor - February 11, 2026

The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...

Vital Information

News

MRD Testing Could Supply Peace of Thoughts to Breast Most cancers Survivors

News

A Household’s Power Via Liver Most cancers and Residing Donation

News

Why Subcutaneous Darzalex Faspro Issues for Sufferers With A number of Myeloma

News

From Missed Indicators to Second Possibilities After a Liver Most cancers Prognosis

News

Keytruda Combo Accredited for Platinum-Resistant Ovarian Most cancers

Editor - February 10, 2026

Chris Draft Shares Steps to Assist Sufferers Regain Management After Most cancers

Editor - February 10, 2026

FDA Quick Observe Designation Highlights New Possibility in Superior Liver Most cancers

Editor - February 10, 2026

In search of a Dose of Hope Amidst Most cancers

Editor - February 10, 2026

FDA Clears Part 2b Research of Teverelix in Superior Prostate Most cancers

Editor - February 10, 2026

When Most cancers Care Turns into a Logistical Balancing Act

Editor - February 9, 2026

Research Hyperlinks Drug Remedy to Fewer Sizzling Flashes Throughout Prostate Most cancers Care

Facts

Why Breast Most cancers Care Is not One Measurement Matches All

February 9, 2026

Mother of 4 Shares Story of Her Breast Most cancers Prognosis

February 9, 2026

Most cancers Anniversaries Good and Unhealthy

February 9, 2026

A Liver Most cancers Journey Marked by Persistence, Household and Hope

February 9, 2026

FDA Grants Designation to Immunotherapy KB707 for Superior NSCLC

February 9, 2026

Knowledgeable Explains Adjuvant Temozolomide Boosts Astrocytoma Survival

February 8, 2026

Latest Articles

Stomach

Building of an immune-related threat rating signature for gastric most cancers primarily based on multi-omics knowledge

Editor - July 6, 2024

Smyth, E. C. et al. Gastric most cancers. Lancet 396(10251), 635–648 (2020).Article CAS PubMed ...

Breast

Hina Khan shares emotional video of getting her hair chopped after most cancers analysis: ‘Determined to make use of my very own hair to...

Editor - July 6, 2024

In a show of power and resilience, actor Hina Khan lately shared her journey with stage three breast most cancers, together with the...

Colorectal

Constant signatures within the human intestine microbiome of old- and young-onset colorectal most cancers

Editor - July 6, 2024

We recruited 460 CRC sufferers from a single hospital in Guangzhou (Strategies). All sufferers had been remedy naïve by the point of enrollment....

Lung

ASCO Studying Room | KRAS Inhibitors and Hepatotoxicity in Lung Most cancers: ‘Not All Results Are Class Results’

Editor - July 6, 2024

Two KRAS inhibitors have earned...

Prostate

Affected person Information to Recurrent and Metastatic Prostate Most cancers

Editor - July 6, 2024

1...1,4481,4491,450...1,671 Page 1,449 of 1,671

Hot Topics

Hodgkin Lymphoma: What Ought to Newly Recognized Sufferers Know?

The Energy of Personalised Care in Breast Most cancers Therapy

Actual-World Knowledge with Amtagvi Present Excessive Response Charges in Superior Melanoma